Mostrar el registro sencillo

dc.contributor.authorChapartegui-González, Itziar
dc.contributor.authorLázaro Diez, María
dc.contributor.authorRedondo Salvo, Santiago
dc.contributor.authorNavas Méndez, Jesús 
dc.contributor.authorRivas, Ramón
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2021-06-28T10:24:06Z
dc.date.available2021-06-28T10:24:06Z
dc.date.issued2021
dc.identifier.issn2079-6382
dc.identifier.otherRED2018-102469-Tes_ES
dc.identifier.urihttp://hdl.handle.net/10902/21924
dc.description.abstractAcinetobacter baumannii is a Gram-negative coccoid rod species, clinically relevant as a human pathogen, included in the ESKAPE group. Carbapenem-resistant A. baumannii (CRAB) areconsidered by the Worl Health Organization (WHO) as a critical priority pathogen for the research and development of new antibiotics. Some of the most relevant features of this pathogen are its intrinsic multidrug resistance and its ability to acquire rapid and effective new resistant determinants against last-resort clinical antibiotics, mostly from other ESKAPE species. The presence of plasmids and mobile genetic elements in their genomes contributes to the acquisition of new antimicrobial resistance determinants. However, although A. baumannii has arisen as an important human pathogen, information about these elements is still not well understood. Current genomic analysis availability has increased our ability to understand the microevolution of bacterial pathogens, including point mutations, genetic dissemination, genomic stability, and pan- and core-genome compositions. In this work, we deeply studied the genomes of four clinical strains from our hospital, and the reference strain ATCC®19606TM, which have shown a remarkable ability to survive and maintain their effective capacity when subjected to long-term stress conditions. With that, our aim was presenting a detailed analysis of their genomes, including antibiotic resistance determinants and plasmid composition.es_ES
dc.description.sponsorshipThis research was funded by ‘Plan Nacional de I+D+i and Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias PI16/01103 to J.R.-V.), Subdirección General de Redes y Centros de Investigación Cooperativa, Spanish Ministry of Economy and Competitiveness, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015) and (REIPI RD16/0016) co-financed by the European Development Regional Fund “A way to achieve Europe” ERDF and Ministerio de Ciencia e Innovación, Acciones de dinamización «Redes de Investigación» RED2018-102469-T.es_ES
dc.format.extent15 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceAntibiotics 2021, 10, 753es_ES
dc.subject.otherAcinetobacter baumanniies_ES
dc.subject.otherESKAPE pathogenses_ES
dc.subject.otherAntimicrobial determinantses_ES
dc.subject.otherPlasmidses_ES
dc.subject.otherBioinformaticses_ES
dc.subject.otherWGSes_ES
dc.subject.otherIlluminaes_ES
dc.titleAntimicrobial Resistance Determinants in Genomes and Plasmids from Acinetobacter baumannii Clinical Isolateses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/antibiotics10070753es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/antibiotics10070753
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International